Grassfed Meat Market Size, Share, Growth, Demand, Trends, and Forecast 2033

The global grassfed meat market, valued at USD 13 billion in 2023, is projected to reach USD 22 billion by 2033, exhibiting a compound annual growth rate (CAGR) of 5.4%. This growth is fueled by increasing consumer awareness of the health benefits associated with grassfed meat, such as lower fat content and higher levels of omega-3 fatty acids, alongside a rising preference for organic and sustainable food options.

The significance of the grassfed meat market extends beyond nutrition, as it supports sustainable agriculture and improved animal welfare, resonating with evolving consumer values. The integration of grassfed meat into restaurant menus and ready-to-eat food products highlights its growing mainstream acceptance. Additionally, advancements in packaging and certifications for organic labeling are enhancing market accessibility, particularly through online retail and hypermarkets.

For more insights into the market, request a sample of this report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=655

Market Analysis

The grassfed meat market is propelled by a global trend toward healthier and more sustainable food choices. Growing awareness of grassfed meat’s benefits, including lower saturated fat and higher concentrations of heart-healthy omega-3 fatty acids, drives consumer demand, particularly among health-conscious demographics. The shift toward clean-label products, coupled with rising concerns about the adverse health effects of inorganic meat, such as high cholesterol and poor heart health, further accelerates market growth. Additionally, the increasing inclusion of grassfed meat in restaurant menus reflects changing consumer dining preferences, boosting market revenue. The rise of online retail channels and advancements in packaging technology also facilitate broader market access, enabling producers to meet growing demand efficiently.

Segment Analysis

The grassfed meat market is characterized by its diverse segmentation, with processed meat dominating approximately 60% of the market share due to its versatility in ready-to-eat products and culinary applications. Raw meat, while significant, holds a smaller share, driven by demand for gourmet and home-cooked meals. By animal type, beef leads the market, fueled by consumer preference for grassfed beef’s health benefits and rich flavor, followed by poultry and lamb. In terms of nature, organic grassfed meat is gaining traction due to consumer demand for chemical- and antibiotic-free products, supported by certifications that ensure authenticity. The end-use segment sees strong demand from the foodservice industry, including restaurants and food trucks, where grassfed meat enhances menu offerings.

Country-wise Insights

In the United States, the grassfed meat market holds a significant 40% share of the global market, valued at approximately USD 5.2 billion in 2023, with a projected CAGR of 5.6% through 2033. The U.S. benefits from a strong consumer base prioritizing health and sustainability, supported by robust distribution networks and increasing availability of grassfed beef in mainstream grocery stores. Initiatives to promote domestic grassfed beef, despite competition from cheaper imports, further drive growth. In the United Kingdom, the market is expected to grow at a CAGR of 5.2%, reaching USD 1.1 billion by 2033.

Key Players

  • JBS Foods
  • Perdue Farms
  • Tyson Foods
  • Verde Farms
  • Creekstone Farms

Strategic Outlook and Industry Trends

The grassfed meat market is undergoing a transformation driven by innovation and consumer-driven trends. The growing popularity of grassfed meat in restaurants reflects a shift toward premium, health-focused dining options, with chefs incorporating grassfed beef into gourmet dishes. Manufacturers are investing heavily in research and development to replace artificial preservatives with organic alternatives, aligning with the clean-label movement. The rise of online retail platforms has expanded market reach, enabling producers to tap into global demand for sustainable meat products. Additionally, social media campaigns highlighting the health and environmental benefits of grassfed meat are boosting consumer awareness and driving sales. To remain competitive, companies must navigate regulatory challenges, such as USDA organic certifications, and address cost barriers by optimizing production processes. Strategic partnerships and investments, such as those seen in the U.S. with companies like Cream Co. Meats, are critical for scaling domestic production and competing with low-cost imports. The market’s future lies in balancing affordability with sustainability while meeting the rising demand for high-quality, eco-conscious meat products.

Explore More Related Studies Published by Fact.MR Research:

Alkalized Cocoa Powder Market
https://www.einpresswire.com/article/816128991/alkalized-cocoa-powder-market-is-predicted-to-reach-a-size-of-usd-1-8-billion-at-a-cagr-of-4-3-by-2035

Cocoa Nibs Market
https://www.einpresswire.com/article/816734920/cocoa-nibs-market-to-surpass-us-1-2-billion-expanding-at-6-8-cagr-by-2035-fact-mr-analysis

 

Segmentation of Grassfed Meat Market

  • By Product:
    • Raw Meat
    • Processed Meat
  • By Animal Type:
    • Beef
    • Poultry
    • Lamb
    • Others
  • By Nature:
    • Organic
    • Conventional
  • By End Use:
    • Foodservice
    • Retail
    • Others
  • By Sales Channel:
    • Hypermarkets/Supermarkets
    • Online Retail
    • Specialty Stores
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Contact

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

 

 

Comments

Post a Comment

Popular posts from this blog

Novel Drug Delivery Systems (NDDS) Market Size, Share, Growth, Trends, and Forecast 2025-2035

The global   Novel Drug Delivery Systems (NDDS) Market   is set for substantial growth, valued at USD 89.7 billion in 2025 and projected to reach USD 172.9 billion by 2035, registering a compound annual growth rate (CAGR) of 6.8%. This growth is fueled by the rising demand for targeted, effective, and minimally invasive treatments for chronic diseases, oncology, and personalized medicine. The increasing focus on optimizing drug bioavailability, enhancing patient compliance, and minimizing side effects is revolutionizing drug delivery and formulation. NDDS encompasses advanced platforms such as transdermal patches, inhalers, liposomes, nanoparticles, implantable pumps, and microneedle systems, transforming therapeutic outcomes across various medical fields. The significance of this market lies in its ability to address critical challenges in traditional pharmacotherapy. With chronic diseases like cancer, diabetes, and cardiovascular conditions affecting millions globally—14.1 m...
Read more

Venous Procedure Devices Market Size, Share & Growth Outlook to 2035

The global   Venous Procedure Devices Market   is valued at approximately USD 2.2 billion in 2025 and is projected to surpass USD 4.1 billion by 2035, expanding at a compound annual growth rate (CAGR) of 6.4%. This growth is driven by the rising prevalence of cardiovascular diseases, increasing demand for minimally invasive procedures, and technological advancements in devices such as stents and catheters. The market is critical for addressing vascular conditions like deep vein thrombosis (DVT) and peripheral arterial disease (PAD), which affect millions globally, with the CDC estimating 900,000 annual DVT cases in the U.S. alone. The shift toward less invasive treatments and the growing adoption of advanced diagnostic tools are further propelling market expansion. The significance of this market lies in its role in improving patient outcomes through innovative devices that enable precise diagnostics and treatments. Venous procedure devices, including catheters, stents, and gu...
Read more

Central Venous Catheters (CVCs) Market Size, Growth Opportunities, and Forecast to 2035

The global   Central Venous Catheters (CVCs) Market   is on a steady growth path, valued at USD 1.5 billion in 2025 and projected to reach USD 2.7 billion by 2035, growing at a compound annual growth rate (CAGR) of 6.0%. This growth is fueled by the rising prevalence of chronic diseases such as cancer and kidney failure, increasing surgical procedures, and advancements in catheter technology. Central venous catheters are critical medical devices used for administering medications, fluids, nutrients, and monitoring hemodynamic status in critical care, oncology, and long-term treatment settings. The market’s expansion is further supported by the growing geriatric population and the increasing demand for minimally invasive procedures. The significance of this market lies in its essential role in modern healthcare, particularly for patients requiring long-term intravenous access. With an estimated 19.3 million new cancer cases globally in 2020 and chronic kidney disease affecting ...
Read more